… therapeutic strategies. In this opinion article, we will discuss recent developments in the
treatment of SCLC, focused on current understanding of the signaling pathways, the role of …

… (NSCLC) and Small cell lung cancers (SCLC), have responded effectively to chemo-, …
adjuvant-therapies. Tumor removal through surgery also appeared as a good therapeutic strategy. …

… therapeutic strategies combining trametinib with an FGFR1 inhibitor could be effective in
treating some KRAS-mutant lung cancers … against FGFR1-amplified lung cancer (Extended Data …

… for novel therapeutic strategies for lung cancer is clear. Several such strategies are under
development, and we will review some aspects of two such classes here: gene therapy and …

… therapeutic strategies of … lung cancer in China is estimated and may increase by approximately
40% from 2015 to 2030. Thus, the public health and therapeutic strategies for lung cancer…

… remarkably to the same therapy [15, 16]… therapy has transformed the face of lung cancer
treatment. Despite great promises brought about by the new paradigm of cancer targeted therapy…

We have unveiled a synthetic lethal interaction between K-Ras oncogenes and Cdk4 in a
mouse tumor model that closely recapitulates human non-small cell lung carcinoma (NSCLC). …

… the therapeutic strategies … therapeutic strategies currently being applied in preclinical or
clinical trials and discusses future directions in the context of novel diagnostic and therapeutic …

… Antibody and biologic therapy Better understanding of the biology of SCLC has led to the
evaluation of novel therapeutic strategies. In an effort to enhance immune surveillance, …

After the massive approval of checkpoint inhibitors in the treatment of numerous malignancies
and settings, checkpoint inhibitors-based combination therapies are emerging as a new …